Prosecution Insights
Last updated: October 04, 2026

Asem Ip Counsel

Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics • Medical Devices & Mechanical Engineering

8 pending office actions • 8 clients • 8 examiners • 5 art units • 0 of 8 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Analysis

ASEM IP COUNSEL specializes in Biotechnology & Pharmaceuticals, managing 139 career applications. The firm has a resolved allowance rate pct of 81.13. This rate demonstrates the firm's ability to navigate the complexities of biotech patent prosecution. The 81.13 percent allowance rate is a primary metric for evaluating the firm's historical performance in securing patent grants. Practitioners can use this percentage to understand the firm's track record across its career filings.

The firm has 6 pending office actions at this time. The average of 2.23 office actions per allowance provides a specific measure of the effort required to secure a patent grant. This 2.23 average helps in setting expectations for the number of interactions required to reach a final decision. With 139 applications in its history, the firm has a documented record of performance. The 6 pending office actions represent the current volume of active matters the firm is pursuing.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=139 apps, methodology: how we score firms)

81.1%
Allowance Rate
n=139
+0.51σ
Allowance Rate (norm)
n=139
2.2
OAs to Allowance
n=86
-0.68σ
OAs to Allow (norm)
n=86
910 days
Time to Allowance
n=86
+7.5pp
Interview Lift
n=139
14.2%
RCE Rate
n=139
0.0%
Appeal Rate
n=139

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=10 (min 20)
52.8%
§102 Overcome
n=36
56.1%
§103 Overcome
n=66
65.2%
§112 Overcome
n=66

Specialization & Scale

A61K, G01N, A61P
Top CPC Subclasses
17%
Top-3 CPC Share
n=139
0
Practitioners
n=139
—
Apps / Practitioner
n=139 (min 20)

Portfolio Summary

8
Total Pending OAs
3
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (62%)
2
Medium (25%)
1
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (25%)
§112 only1 (12%)
Multi-statute (no §101)5 (62%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
25% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
12% of docket
2
Mechanical / Eng
25% of docket
3
Business / Other
38% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

80 h
Manual time on pending OAs
16 h
Time saved (low, 20%)
28 h
Time saved (mid, 35%)
0.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
THEIS, MATTHEW T 1 42.1% +32.5%
KOCH, GEORGE R 1 72.9% +17.3%
OLIVER, BRADLEY S 1 60.9% +14.3%
NGUYEN, PHUONG T 1 73.8% +37.0%
KASSA, TIGABU 1 36.7% +27.9%
OGLES, MATTHEW ERIC 1 50.0% +57.0%
WESTERBERG, NISSA M 1 23.4% +37.1%
BARZYKIN, VICTOR V 1 82.3% +3.7%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18044197 BIO-SIGNAL MEASUREMENT BAND OGLES, MATTHEW ERIC 105d overdue
18073624 FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF WESTERBERG, NISSA M 13d
19035956 PARTIAL EASY-PEEL POUCH AND METHOD FOR MANUFACTURING SAME THEIS, MATTHEW T —
19015625 DIE EJECTOR KOCH, GEORGE R —
18847246 OVERCAP WITH TUBE SHAPE FOR STICK-TYPE COSMETIC CONTAINER OLIVER, BRADLEY S —
17983904 COLOR IMAGE SENSOR AND MANUFACTURING METHOD THEREOF BARZYKIN, VICTOR V —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18044197 BIO-SIGNAL MEASUREMENT BAND OGLES, MATTHEW ERIC 105d overdue
18073624 FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF WESTERBERG, NISSA M 13d
19035956 PARTIAL EASY-PEEL POUCH AND METHOD FOR MANUFACTURING SAME THEIS, MATTHEW T —
19015625 DIE EJECTOR KOCH, GEORGE R —
18847246 OVERCAP WITH TUBE SHAPE FOR STICK-TYPE COSMETIC CONTAINER OLIVER, BRADLEY S —
18427998 METHOD FOR MANUFACTURING ELECTROSTATIC CHUCK NGUYEN, PHUONG T —
18267459 METHOD FOR PREPARING PHARMACEUTICAL FORMULATION OF TABLET CONTAINING TRIZOLOPYRAZINE DERIVATIVE AS AN ACTIVE INGREDIENT KASSA, TIGABU —

Client Portfolio (8 clients)

Top Art Units

Art UnitApps
37541
16191
37911
16181
28931

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19035956 PARTIAL EASY-PEEL POUCH AND METHOD FOR MANUFACTURING SAME Myungji Pandp Co., Ltd. THEIS, MATTHEW T §102§103§112 Non-Final OA — Pending Jan 24, 2025
19015625 DIE EJECTOR Flc KOCH, GEORGE R §102§103 Non-Final OA — Pending Jan 09, 2025
18847246 OVERCAP WITH TUBE SHAPE FOR STICK-TYPE COSMETIC CONTAINER Nf Beauty Group Korea Co., Ltd. OLIVER, BRADLEY S 3754 §103§112 Final Rejection — Pending Sep 14, 2024
18427998 METHOD FOR MANUFACTURING ELECTROSTATIC CHUCK Samsung Electronics Co., Ltd. NGUYEN, PHUONG T §103 Non-Final OA — Pending Jan 31, 2024
18267459 METHOD FOR PREPARING PHARMACEUTICAL FORMULATION OF TABLET CONTAINING TRIZOLOPYRAZINE DERIVATIVE AS AN ACTIVE INGREDIENT Abion Inc. KASSA, TIGABU 1619 §103 Final Rejection — Pending Jun 15, 2023
18044197 BIO-SIGNAL MEASUREMENT BAND Hhs Co., Ltd. OGLES, MATTHEW ERIC 3791 §103§112 Final Rejection 105d overdue Pending Mar 06, 2023
18073624 FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF BIOACTS CORPORATION WESTERBERG, NISSA M 1618 §112Other Final Rejection 13d Pending Dec 02, 2022
17983904 COLOR IMAGE SENSOR AND MANUFACTURING METHOD THEREOF Sensohub Co., Ltd. BARZYKIN, VICTOR V 2893 §103§112 Final Rejection — Pending Nov 09, 2022

Managing Asem Ip Counsel's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month